← Open Payments lookup

KELLY KOLLMAN: Open Payments

NPI 1710053533 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,700 in 79 payments from 20 companies in 2025. Trend: 2023 $945 · 2024 $1,392 · 2025 $1,700

Food & beverage: $1,700
CompanyPaymentsAmount
ABBVIE INC.20$425
Janssen Biotech, Inc.10$259
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$171
Lilly USA, LLC6$151
PFIZER INC.5$97
Ardelyx, Inc.3$84
GENZYME CORPORATION2$72
Ipsen Biopharmaceuticals, Inc3$66
Takeda Pharmaceuticals U.S.A., Inc.2$65
Madrigal Pharmaceuticals2$57

Products named: TREMFYA, RINVOQ, XIFAXAN, MAVYRET, DUPIXENT, OMVOH, IBSRELA, VELSIPITY.

Industry payments across AZ — which companies pay providers there.